University of Miami, Department of Urology, Miller School of Medicine-1400 NW 12th Ave, Miami, FL 33136.
University of Miami, Department of Urology, Miller School of Medicine-1400 NW 12th Ave, Miami, FL 33136.
Urology. 2021 Aug;154:342-343. doi: 10.1016/j.urology.2021.04.028. Epub 2021 May 8.
To demonstrate technique of salvage thylium fiber laser enucleation of prostate in men with history of prior prostatic urethral lift (PUL) implant. PUL is an accepted treatment modality for benign prostatic hyperplasia (BPH) and is currently recommended for surgical management of prostates <80 g in size. However, in reality some patients with prostate >80 g also receive PUL. A substantial number of these patients may requirement re-treatment for recurrent or persistent lower urinary tract symptoms after PUL. Patients with larger prostates who fail PUL might be better managed with endoscopic enucleation which is a size-independent modality for treatment of BPH. Endoscopic enucleation can be accomplished via a variety of energy sources. Thulium fiber laser is a new addition to urologist armamentarium for endoscopic enucleation of prostate. We hereby present a video demonstrating salvage thulium fiber laser enucleation of 198 cc prostate in a men with history of prior PUL.
A 66-year-old male presented with a history of recurrent urine retention after prior PUL done 2 years prior at an outside institution. Pre-operative international prostate symptom score was 13, maximum uroflow rate was 6.1 ml/sec, residual urine was 26 ml despite maximal medical management. MRI demonstrated a 198 g prostate and PSA was 13.4 ng/dl with negative prostate biopsy. After a detailed discussion of options, he elected endoscopic enucleation. We employed a 550-micron Soltive superpulsed laser fiber set at 2 J and 30 Hz to perform en-bloc enucleation of prostate, and morcellation was performed with the VersaCut Morcellator. We edited the video to demonstrate the technical nuances of this procedure.
Surgery was uneventful with enucleation time of 70 minutes and morcellation time of 142 minutes. Implants encountered during enucleation were easily separated with the thulium fiber laser. No attempt was made to remove implants segments extending beyond the plane of enucleation. Morcellation was challenging, with evidence of damage to morcellation probes requiring replacement of 3 morcellator probes. The patient was discharged on post-operative day one after successful voiding trial. At six-week follow up, his international prostate symptom score of 3 with maximum urinary flow rate of 50 mL/sec. He reported no urinary incontinence and his pathology demonstrated BPH.
This video demonstrates the feasibility of thulium fiber laser enucleation of prostate after PUL, however the findings need to be reproduced in cohort studies. It also demonstrates difficulties encountered during morcellation. For smaller prostates, vaporization may be preferable, thereby avoiding difficulties associated with morcellation.
展示经尿道前列腺钬激光剜除术治疗既往前列腺尿道吊带(PUL)植入术后患者的技术。PUL 是治疗良性前列腺增生(BPH)的一种公认的治疗方法,目前推荐用于前列腺体积 <80g 的手术治疗。然而,实际上一些前列腺体积 >80g 的患者也接受了 PUL 治疗。大量接受 PUL 治疗的患者在 PUL 后可能会出现下尿路症状复发或持续存在,需要再次治疗。对于前列腺体积较大且 PUL 治疗失败的患者,可通过内镜前列腺剜除术进行更好的治疗,这是一种与前列腺体积无关的治疗 BPH 的方法。内镜前列腺剜除术可以通过多种能源完成。钬激光光纤是泌尿科医生进行前列腺剜除术的新工具。本文通过视频演示了一例既往在其他机构行 PUL 治疗 2 年后出现复发性尿潴留的 66 岁男性患者,使用经尿道前列腺钬激光剜除 198cc 前列腺。
一名 66 岁男性患者因既往在其他机构行 PUL 治疗 2 年前出现复发性尿潴留而就诊。术前国际前列腺症状评分(IPSS)为 13 分,最大尿流率为 6.1ml/sec,残余尿量为 26ml,尽管接受了最大程度的药物治疗。MRI 显示前列腺体积为 198g,PSA 为 13.4ng/dl,前列腺活检为阴性。在详细讨论了各种选择后,他选择了内镜前列腺剜除术。我们使用 550 微米 Soltive 超脉冲激光光纤,设置为 2J 和 30Hz 进行前列腺整块剜除,使用 VersaCut 切碎器进行切碎。我们编辑了视频,以演示该手术的技术要点。
手术过程顺利,剜除时间为 70 分钟,切碎时间为 142 分钟。在剜除过程中遇到的植入物很容易被钬激光光纤分离。我们没有试图移除超出剜除平面的植入物。切碎过程具有挑战性,切碎探头受损,需要更换 3 个切碎探头。患者在成功进行排尿试验后于术后第 1 天出院。在 6 周的随访中,他的国际前列腺症状评分(IPSS)为 3 分,最大尿流率为 50ml/sec。他没有出现尿失禁,术后病理显示为良性前列腺增生。
该视频展示了经尿道前列腺钬激光剜除术治疗 PUL 术后前列腺的可行性,但需要在队列研究中重复这些发现。它还展示了在切碎过程中遇到的困难。对于较小的前列腺,汽化可能更可取,从而避免与切碎相关的困难。